Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of the polycomb-group gene BMI1 is related to an unfavourable prognosis in primary nodal DLBCL

12 Jul 2006

Abstract excerpt

BACKGROUND: Clinical outcome in patients with diffuse large B cell lymphomas (DLBCL) is highly variable and poorly predictable. Microarray studies showed that patients with DLBCL with a germinal centre B cell-like (GCB) phenotype have a better prognosis than those with an activated B cell-like (ABC) phenotype. The BMI1 proto-oncogene was identified as one of the genes present in the signature of the ABC type of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Chronic Myeloid Leukemia Treatments
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16837630
DOI: 10.1136/jcp.2006.038752

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of the polycomb-group gene BMI1 is related to an unfavourable prognosis in primary nodal DLBCLPMID 16837630Read ↗

BMI1: A Biomarker of Hematologic MalignanciesSemantic proximity Read ↗

Implication of Polycomb Members Bmi-1, Mel-18, and Hpc-2 in the Regulation of p16INK4a, p14ARF, h-TERT, and c-Myc Expression in Primary Breast CarcinomasSemantic proximity Read ↗

Loss of the human polycomb group protein BMI1 promotes cancer-specific cell deathSemantic proximity Read ↗

BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases.Semantic proximity Read ↗

Immunohistochemical profiling based on Bcl‐2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphomaSemantic proximity Read ↗

BMI1 as a novel target for drug discovery in cancerSemantic proximity Read ↗

BMI1, the polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphoma.Semantic proximity Read ↗

Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemiaSemantic proximity Read ↗

BMI-1, a promising therapeutic target for human cancerSemantic proximity Read ↗

Overexpression of polycomb protein BMI-1 in human specimens of breast, ovarian, endometrial and cervical cancer.Semantic proximity Read ↗

The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemiaSemantic proximity Read ↗

BMI-1 Promotes Ewing Sarcoma Tumorigenicity Independent of <i>CDKN2A</i> RepressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.